Literature DB >> 33666084

DUSP1 Promotes Microglial Polarization toward M2 Phenotype in the Medial Prefrontal Cortex of Neuropathic Pain Rats via Inhibition of MAPK Pathway.

Ximei Wang1, Yuan Jiang1, Jingyi Li1, Yunjiao Wang1, Ying Tian1, Qulian Guo1, Zhigang Cheng1.   

Abstract

Shifting microglial polarization from M1 toward M2 phenotype represents a promising therapeutic strategy for neuropathic pain (NP). Dual-specificity phosphatase-1 (DUSP1) is a key component in regulating anti-inflammatory response. The medial prefrontal cortex (mPFC) is implicated in emotional disorders associated with NP and constitutes a neuroanatomical substrate for exploring mechanisms underlying NP. This study aims to investigate whether DUSP1 regulates microglial M1/M2 polarization in the mPFC in a rat model of NP. Rat model of NP was established by chronic constriction injury (CCI) of the rat sciatic nerve. Lipopolysaccharide (LPS) was used to activate HAPI rat microglial cells as an in vitro inflammatory model. CCI-induced decreased pain threshold, increased cell apoptosis in mPFC, elevated pro-inflammatory M1/M2 microglia ratio, and activated MAPK signaling in the mPFC of rats. Importantly, intra-mPFC injection of DUSP1-expressing lentivirus counteracted these abnormalities. In vitro assay further confirmed that DUSP1 overexpression switched microglial M1 to M2 polarization through inhibition of MAPK signaling activation. DUSP1 switched microglial M1 to M2 polarization in the mPFC and attenuated CCI-induced NP by inhibiting the MAPK signaling.

Entities:  

Keywords:  DUSP1; M1/M2 polarization; MAPK; Neuropathic pain; microglia

Mesh:

Substances:

Year:  2021        PMID: 33666084     DOI: 10.1021/acschemneuro.0c00567

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  5 in total

1.  DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation.

Authors:  Long-Qing Zhang; Shao-Jie Gao; Jia Sun; Dan-Yang Li; Jia-Yi Wu; Fan-He Song; Dai-Qiang Liu; Ya-Qun Zhou; Wei Mei
Journal:  J Neuroinflammation       Date:  2022-06-03       Impact factor: 9.587

2.  Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization.

Authors:  Jiaqi Yuan; Yue Fei
Journal:  Open Med (Wars)       Date:  2022-05-13

3.  Kaempferol exerts a neuroprotective effect to reduce neuropathic pain through TLR4/NF-ĸB signaling pathway.

Authors:  Shiquan Chang; Xin Li; Yachun Zheng; Huimei Shi; Di Zhang; Bei Jing; Zhenni Chen; Guoqiang Qian; Guoping Zhao
Journal:  Phytother Res       Date:  2022-03-02       Impact factor: 6.388

4.  Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress.

Authors:  Timea Aczél; Bettina Benczik; József Kun; Zsuzsanna Helyes; Bence Ágg; Tamás Körtési; Péter Urbán; Witold Bauer; Attila Gyenesei; Bernadett Tuka; János Tajti; Péter Ferdinandy; László Vécsei; Kata Bölcskei
Journal:  J Headache Pain       Date:  2022-09-02       Impact factor: 8.588

5.  RNA interference-mediated silencing of DNA methyltransferase 1 attenuates neuropathic pain by accelerating microglia M2 polarization.

Authors:  Ying Tan; Zongjiang Wang; Tao Liu; Peng Gao; Shitao Xu; Lei Tan
Journal:  BMC Neurol       Date:  2022-10-01       Impact factor: 2.903

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.